FLEDGE Members enjoy a supportive, collaborative working environment with access to prototyping facilities, regular mentoring sessions, and an extensive MedTech network.
Real-time monitoring of vital signs for hospital inpatients. VitaMon™ is being developed to monitor ECG, respiration, SpO2, temperature, cuff-less BP, location and kinematics in real-time. Coupled with an AI expert system, VitaMon™ will enable early intervention by predicting healthdegradation.
Movandi pioneered the development of RF CMOS including the integration of multiple standards into a single chip – and now are enabling 5G and other multi-gigabit networks by providing cost effective, scalable, integrated RF, antenna technology and systems.
NZX-listed TruScreen detects pre-cancerous changes in cervical cells, or cervical intraepithelial neoplasia (CIN), using optical and electrical measurements of cervical tissue. TruScreen’s technology is twice as sensitive as a PAP test and significantlymore sensitive than HPV DNA testing.
Building non-contact VR interfaces and immersive content for people living with cerebral palsy (CP), acquired brain injury, spinal cord injury, stroke and neuro-muscular disorders.
Respiration Enhancement & Support for Preterm Infants
Reducing the mortality rate of preterm infants in resource-limited countries.
The Clean Air Association of Australia was established to raise the level of community awareness of issues relating to the reduction of air pollution and improvement of air quality.
FreshTracks is developing an activity-based program to simulate the brain, improve strength and build social connections in young people who have suffered an acquired brain injury. This is based on a customised VR experience driven by a patient riding a stationary recumbent bicycle.
Indee Labs develops systems for the efficient development and scalable manufacturing of gene-modified cell therapies based on microfluidic vortex shedding, which enables rapid processing of human primary immune cells,
Oncosil Medical Limited (ASX : OSL)
ASX-listed Oncosil is developing an active implantable brachytherapy system for cancer treatment, based on Phosphorous-32 Microparticles injected into a tumour using endoscopic ultrasound guidance, particularly for treating cancers of the pancreas and liver.
The Sensory-Motor Active Rehabilitation Training Arm (SMART Arm) is a device that enables stroke survivors with upper limb weakness to drive recovery of their arm.
Sana Health Intelligence
Technologies to empower everyone to self-monitor and better manage health & wellness, with a focus on aged care.
Providing intuitive and user-focussed products that help create Virtual Reality experiences, with a long-term vision to include incredibly immersive haptic feedback.
Building VR experiences for the evaluation and treatment of phobias.
A free-swimming autonomous robot for cleaning objects in marine environments, including boat hulls, aqua-farms and fixed structures.
FLEDGE Fund investments
- NSW = $275,000
- Federal = $500,000